Advertisement

European Journal of Epidemiology

, Volume 18, Issue 4, pp 351–354 | Cite as

Serosurvey among Mediterranean spotted fever patients of a new spotted fever group rickettsial strain (Bar29)

  • Neus Cardeñosa
  • Ferran Segura
  • Didier Raoult
Article

Abstract

Mediterranean spotted fever is an endemic disease in Catalonia, Spain. A new spotted fever group (SFG) rickettsial strain (Bar29) of unknown pathogenicity for humans was isolated by our group, in 1996, from the dog brown tick, Rhipicephalus sanguineus. Interestingly, Rickettsia conorii was not isolated in this study. The aim of the present study was to assess the possible pathogenic role of the Bar29 strain. To this purpose, serum samples from 15 patients with Mediterranean spotted fever were obtained and tested by immunofluorescence for antibodies against four related rickettsial strains (R. conorii, R. africae, R. massiliae, and Bar29). Eight of the studied sera reacted at high titers with only R. conorii and Bar29 antigens. For five of the eight sera, the titers against Bar29 were clearly higher than for R. conorii. Four of these sera were also studied by Western blot immunoassay to confirm a specific response. Two of these sera reacted with the high-molecular-mass specific proteins of Bar29 as well as with the low-molecular-mass region (LPS antigen) whereas their reactions with R. conorii were located only on bands of the LPS. This specific response would support the possible pathogenic role of the Bar29 strain for humans. According to this finding, spotted fever caused by R. conorii and rickettsial strain Bar29 may be present in our area. The epidemiological implications of spotted fever caused by R. conorii and by rickettsial strain Bar29 in the Catalonia deserve further studies with isolation and characterization of more rickettsial strains.

Mediterranean spotted fever Rickettsioses Rickettsia conorii Tick infestations 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Uchida T, Yu XJ, Uchiyama T, Walker DH. Identification of a unique spotted fever group rickettsia from humans in Japan. J Infect Dis 1989; 159: 1122–1126.Google Scholar
  2. 2.
    Baird RW, Stenos J, Stewart R, et al. Genetic variation in Australian spotted fever group rickettsiae. J Clin Microbiol 1996; 34: 1526–1530.Google Scholar
  3. 3.
    Eremeeva ME, Beati L, Makarova VA, et al. Astrakhan fever rickettsia: Antigenic and genotypic analysis of isolates obtained from human and Rhipicephalus pumilio ticks. Am J Trop Med Hyg 1994; 51: 697–706.Google Scholar
  4. 4.
    Kelly PJ, Beati L, Mason PR, Matthewman LA, Roux V, Raoult D. Rickettsia africae sp. nov., the etiological agent of African tick bite fever. Int J Syst Bacteriol 1996; 46: 611–614.Google Scholar
  5. 5.
    Higgins JA, Radulovic S, Schriefer ME, Azad AF. Rickettsia felis: A new species of pathogenic rickettsia isolated from cat fleas. J Clin Microbiol 1996; 34: 671–674.Google Scholar
  6. 6.
    Raoult D, Brouqui P, Roux V. A new spotted-fevergroup rickettsiosis. Lancet 1996; 348: 412.Google Scholar
  7. 7.
    Raoult D, Fournier PE, Abboud P, Caron F. First documented human Rickettsia aeschlimanii infection. Emerg Infect Dis 2002; 8: 748–749.Google Scholar
  8. 8.
    Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997; 10: 694–719.Google Scholar
  9. 9.
    Beati L, Roux V, Ortuño A, Castella J, Segura-Porta F, Raoult D. Phenotypic and genotypic characterization of spotted fever group rickettsiae isolated from Catalan Rhipicephalus sanguineus ticks. J Clin Microbiol 1996; 34: 2688–2694.Google Scholar
  10. 10.
    Cardeñosa N, Roux V, Font B, Sanfeliu I, Raoult D, Segura F. Isolation and identification of two spotted fever group rickettsial strains from patients in Catalonia, Spain. Am J Trop Med Hyg 2000; 62: 142–144.Google Scholar
  11. 11.
    Cardeñosa N, Sanfeliu I, Segura F. Diagnóstico microbiológico de las rickettsiosis. Enf Infecc Microbiol Clin 1997; 15: 32–37.Google Scholar
  12. 12.
    Bell EJ, Stoenner HG. Immunologic relationships among the spotted fever group of rickettsias determined by toxin neutralization tests in mice with convalescent animal serums. J Immunol 1960; 84: 171–210.Google Scholar
  13. 13.
    Brouqui P, Harle JR, Delmont J, Frances C, Weiller PJ, Raoult D. African tick bite fever: An imported spotless rickettsiosis. Arch Intern Med 1997; 157: 119–124.Google Scholar
  14. 14.
    Beati L, Raoult D. Rickettsia massiliae sp. nov., a new spotted fever group rickettsia. Int J Syst Bacteriol 1993; 43: 839–840.Google Scholar
  15. 15.
    Babalis T, Tselentis Y, Roux V, Psaroulaki A, Raoult D. Isolation and identification of a rickettsial strain related to Rickettsia massiliae in Greek ticks. Am J Trop Med Hyg 1994; 50: 365–372.Google Scholar
  16. 16.
    Bacellar F, Regnery RL, Núncio MS, Filipe AR. Genotypic evaluation of rickettsial isolates recovered from various species of ticks in Portugal. Epidemiol Infect 1995; 114: 169–178.Google Scholar
  17. 17.
    Weiss E, Coolbaugh JC, Williams JC. Separation of viable Rickettsia typhi from yolk-sac and L-cell host components by renografin density gradient centrifugation. Appl Microbiol 1975; 30: 456–463.Google Scholar
  18. 18.
    Philip RN, Casper EA, Ormsbee RA, Peacock MG, Burgdorfer W. Microimmunofluorescence test for the serological study of Rocky Mountain spotted fever and typhus. J Clin Microbiol 1976; 3: 51–61.Google Scholar
  19. 19.
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.Google Scholar
  20. 20.
    Raoult D, Hechemy KE, Chaudet H. Sérologie de la fièvre boutonneuse mediterranèene. Cinétique des anticorps détectés par trois mèthodes: l'immunofluorescence indirecte, l'hémagglutination indirecte et l'agglutination latex. Pathol Biol 1985; 33: 839–841.Google Scholar
  21. 21.
    Newhouse VF, Shepard CC, Redus MD, Tzianabos T, McDade JE. A comparison of the complement fixation, indirect fluorescent antibody, and microagglutination tests for the serological diagnosis of rickettsial diseases. Am J Trop Med Hyg 1979; 28: 387–395.Google Scholar
  22. 22.
    Beati L, Kelly PJ, Mason PR, Raoult D. Species-specific BALB/c mouse antibodies to rickettsiae studied by western blotting. FEMS Microbiol Lett 1994; 119: 339–344.Google Scholar
  23. 23.
    Raoult D, Dasch GA. Line blot and western blot immunoassays for diagnosis of Mediterranean spotted fever. J Clin Microbiol 1989; 27: 2073–2079.Google Scholar
  24. 24.
    Teysseire N, Raoult D. Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever. J Clin Microbiol 1992; 30: 455–460.Google Scholar
  25. 25.
    Raoult D, Dasch GA. Immunoblot cross-reactions among Rickettsia, Proteus spp. and Legionella spp. in patients with Mediterranean spotted fever. FEMS Immunol Med Microbiol 1995; 11: 13–18.Google Scholar
  26. 26.
    Raoult D, Arzouni JP, Jambon MC, Beytout J, Ramousse O. Western blot as a seroepidemiological tool for detecting foci of Mediterranean spotted fever (MSF). Eur J Epidemiol 1994; 10: 37–40.Google Scholar
  27. 27.
    Herrero JI, Ruiz R, Walker DH. La técnica de Western immunoblotting en situaciones atípicas de infección por Rickettsia conorii. Presentación de 2 casos. Enf Infecc Microbiol Clin 1993; 11: 139–142.Google Scholar
  28. 28.
    Brouqui P, Tissot Dupont H, Drancourt M, Bourgeade A, Raoult D. Spotless boutonneuse fever. Clin Infect Dis 1992; 14: 114–116.Google Scholar
  29. 29.
    Ormsbee RA, Peacock MG, Philip R, et al. Antigenic relationships between the typhus and spotted fever groups of rickettsiae. Am J Epidemiol 1978; 108: 53–59.Google Scholar
  30. 30.
    La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: Current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35: 2715–2727.Google Scholar
  31. 31.
    Kelly PJ, Mason PR, Matthewman LA, Raoult D. Seroepidemiology of spotted fever group rickettsial infections in humans in Zimbabwe. J Trop Med Hyg 1991; 94: 304–309.Google Scholar
  32. 32.
    Font-Creus B, Bella-Cueto F, Espejo-Arenas E, et al. Mediterranean spotted fever: A cooperative study of 227 cases. Rev Infect Dis 1985; 7: 635–642.Google Scholar
  33. 33.
    Font-Creus B, Espejo Arenas E, Muñoz Espín T, Uriz Urzainqui S, Bella Cueto F, Segura Porta F. Fiebre botonosa mediterránea. Estudio de 246 casos. Med Clin (Barc) 1991; 96: 121–125.Google Scholar
  34. 34.
    Ruiz Beltran R, Herrero Herrero JI, Martin Sanchez AM, et al. Formas graves de fiebre exantemática mediterránea. Análisis prospectivo de 71 enfermos. An Med Int (Madrid) 1985; 2: 365–368.Google Scholar
  35. 35.
    Segura-Porta F, Font-Creus B, Espejo-Arenas E, Bella-Cueto F. New trends in Mediterranean spotted fever. Eur J Epidemiol 1989; 5: 438–443.Google Scholar
  36. 36.
    Segura-Porta F, Diestre-Ortin G, Ortuño-Romero A, et al. Prevalence of antibodies to spotted fever group rickettsiae in human beings and dogs from an endemic area of mediterranean spotted fever in Catalonia, Spain. Eur J Epidemiol 1998; 14: 395–398.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Neus Cardeñosa
    • 1
  • Ferran Segura
    • 1
  • Didier Raoult
    • 2
  1. 1.Infectious Disease Program, Department of Internal MedicineCorporació Sanitària Parc Taulí, SabadellBarcelonaFrance
  2. 2.Unité des Rickettsies, Faculté de MédecineMarseilleFrance

Personalised recommendations